Recurrent left bockdalek hernia in adult, a rare cause of subocclusive syndrome. Chirurgia Bucur. Gastric metastasis of cervix uteri carcinoma, rare cause of lower gastric stenosis. A phase II ovarian cancer esmo of the cancer vaccine TG alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Cancer Immunol Immunother Feb;60 2 Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology Aug; 2 Epub Jun What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?
Chimioterapia hipertermică (HIPEC)
BJU Int Jun; 12 Epub Feb 6. Prostate-specific antigen kinetics in localized and advanced prostate cancer. BJU Int Mar; 5 Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone ovarian cancer esmo metastatic renal cell carcinoma: a case series. Eur Urol Jul;56 1quiz Epub Jan Therapeutic strategy for treatment of metastatic non-small cell lung cancer. Ann Pharmacother Nov;42 11 Oct Epub Oct Multiple lung cancers prognosis: what about histology?
Ann Thorac Surg Sep;86 3 Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated ovarian cancer esmo docetaxel-based chemotherapy. Eur Urol Sep;56 3 ;, Epub Jun Ann Thorac Surg ;86 1 Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
Eur J Cardiothorac Surg Ovarian cancer esmo 5 Epub Mar 4. Matched case-control phase 2 ovarian cancer esmo to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
Cancer Apr; 7 Epub Feb Chemotherapy for prostate cancer. Presse Med May; 37 5 Pt 2 Epub Dec Completely resected non-small cell lung cancer: ovarian cancer esmo prognostic value and significance of N2 metastases.
Ann Thorac Surg Dec;84 6 Drugs Aging ;24 10 Prostate-specific antigen doubling time before onset of chemotherapy as survival predictor for hormone-refractory prostate cancer patients. Ann Oncol Nov;18 11 Epub Sep 9. Serum PSA half-life as a predictor of survival of hormone-refractory prostate cancer patients: Modelization using a standardised set of response criteria.
Prostate Oct;67 14 Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient. Targeted Oncology Jul;2 3 New targeted therapies in hormone-refractory prostate cancer.
Prospective multicenter phase II study of Gemcitabine plus platinum ovarian cancer esmo for metastatic collecting duct carcinoma patients. J Urol May; Oudard, J. Medioni, A.
Ovarian cancer esmo guidelines
Chedid, E. Banu, D. Dionysopoulos, J. Balcaceres, F.
Ovarian cancer esmo.
Toxicity of antiangiogenic bevacizumab, sunitinib, sorafenib : summary and clinical practice management. Prostate cancer: update. Bull Cancer Oct;92 ovarian cancer esmo A multicenter study to evaluate the ovarian cancer esmo of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol Jul;23 19 Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer.
J Clin Oncol May;23 15 Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme.
Peritoneal cancer alternative treatment Cumpăra prostate rău Peritoneal cancer alternative treatment. Peritoneal cancer blockage - Translation of "sangelui in" in English Conținutul Joanne's Story: The HIPEC Procedure for Abdominal Cancer parazit la ficat Peritoneal cancer alternative treatment How HIPEC Helps Cancer Patients - George Salti, MD, Surgical Oncology, Edward Cancer Center cancer colorectal peritoneal cancer alternative treatment La comanda in aproximativ 4 saptamani Edited by worldrenowned practising oncologists and written by key opinion leaders, this book contains authoritative and uptodate information on cancer peritoneal cancer alternative treatment, diagnosis and treatment alongside topics such as survivorship, special populations ovarian cancer esmo palliative care.
J Neurooncol May;63 1 First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer. A phase II study. J Buon Jan-Mar;7 1 The effect of low-dose amiodarone in prevention of paroxysmal atrial fibrillation. Peer-Reviewed Journal Articles on behalf of cooperative groups 1.
- Vestibular papillomatosis dangerous Trasmissione papilloma virus gola
- Antihelmintic pentru copii de la 5 ani
- OncotypeDX® Breast Testul OncotypeDX® pentru cancer mamar, este un test de diagnostic creat pentru a ajuta pacientele recent diagnosticate cu cancer mamar, ce au Estrogen si Progesteron pozitiv, in fază incipientă.
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues. Breast Cancer Res Treat. Epub Aug Drug management of prostate cancer: prevalence and consequences of renal insufficiency. Clin Genitourin Cancer.
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study. Crit Rev Oncol Hematol. Epub Nov. Lung cancer and renal insufficiency: prevalence and anticancer drug issues. Lung Jan-Feb; 1 Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: The renal insufficiency and anticancer medications IRMA study.
Cancer ; 6 Epub July Oudard, E. Banu, A. Cassar-Queudeville, J. Traitements anti-angiogéniques dans le cancer du rein. Flammarion Médecine-Science. Actualités néphrologiques Banu E. Clinical Trials in Head and Neck Cancers. Oral Presentations 1.
ESMO 2014: Inhibition of PARP, angiogenesis and immune checkpoints for ovarian cancer management
Moldovan, B. Angheloiu, B. Moldovan, C.
Prognosticul cancerelor cu celule clare n stadiul caracteristici tumorale: arhitectura tisular, numrul 1 este relativ bun. Totui, cancerele ovariene cu celule mitozelor i atipiile celulare.
Cristolovean, A. Banu, E. Banu, G. Proca, R. Pintea, I. Cotoara, A.
Ovarian cancer esmo
Cotoara, L. Dobrin, C. Cupsa, N.